LUMENIS INC.
MARLBOROUGH, MA

Don't let glaucoma steal your sight, see how SLT therapy can help control your glaucoma ective Laser Trabeculoplasty, or SLT (pioneered by Lumenis), glaucoma therapy, is an effective and convenient laser surgery for glaucoma we have developed in our ongoing effort to prevent glaucoma from “stealing” vision in glaucoma patients. Glaucoma eye disease is a degenerative disease that if left untreated can cause permanent damage to the optic nerve resulting in gradual vision loss and eventual blindness. Damage to the optic nerve, due to glaucoma, is usually caused by an elevated intraocular pressure (IOP). Clear fluid, called aqueous humor circulates through the eye providing nourishment to the tissues pressure to help maintain the shape of the eye. (OAG), occurs when there is an increase in fluid production or a decrease in fluid drainage. Over time, as the optic nerve fibers are destroyed, peripheral (side) vision is lost. Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards.  Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the sectors we operate in. : The Lumenis name and brand are associated with high quality among consumers. {{company.name}} Thanks for your interest in {{company.name}}. We're sorry, but there are currently no open positions. The name Lumenis originates in Latin and means Light of Life.  As the world-renowned expert in developing and commercializing innovative energy-based technologies, light is central to our technological innovations, but also a symbol of our mission to improve the lives of people with medical and cosmetic conditions. Lumenis is committed to supporting medical community leaders as they reach out to patients in need – no matter where they live – to bring them the life-changing benefits of minimally invasive procedures.  In just the past year, Lumenis has provided technology and resources to help undeserved  and underprivileged populations across the globe. , Lumenis is supporting the efforts of the St. Luke Foundation for Haiti and Dr. Mitchell Humphreys of the Mayo Clinic to provide relief and prevent potentially life-threatening complications in Benign Prostatic Hyperplasia (BPH) patients using the , China and Vietnam, Lumenis worked with acclaimed Dr. Rox Anderson  of Harvard Medical School to treat children suffering from burn injuries. Children at the Pediatric Hospital No. 9 in Moscow were treated using Lumenis’ CO2 laser.  Lumenis donated the laser system to the hospital and Dr. Anderson trained the local doctors so that more children could be helped in the future.  Similar missions with Dr. Anderson were carried out in China and Vietnam where over 300 children were healed. , where glaucoma affects nearly 9% of the population over the age of 30, Lumenis worked with Dr. Tony Realini of West Virginia University to help reduce preventable blindness using the .  Lumenis has also collaborated with the Wills Eye Institute to provide SLT procedures to undeserved patients in Philadelphia. In the United States and Israel, the Lumenis HOPE campaign is helping wounded soldiers gain access to advanced burn treatment with the CO2 laser.  The Company is committed to doing its part to ensure that Veterans wounded in battle receive the best medical care possible, regardless of their ability to pay. Lumenis and Aravind Eye Care System, a social organisation committed to the goal of elimination of needless blindness, are collaborating to evaluate the effect of Selective Laser Trabeculoplasty, a painless laser application, in minimizing glaucoma progression in India. Lumenis has collaborated with Right-to-Sight - a non-profit organization registered at the Royal College of Surgeons in Ireland, to Join fight to eliminate preventable blindness in Africa.  "Glaucoma is responsible for up to 20% of the preventable blindness cases in Africa, yet there is less than one ophthalmic surgeon per one million inhabitants across the continent,” said Dr. Kate Coleman, ophthalmic surgeon and founder of Right-to-Sight. "Furthermore, standard medical treatments such as prostaglandin-analogues are largely unavailable, difficult to store at correct temperatures, and often cost more than a local monthly wage. Right to Sight, together with Lumenis, believes that glaucoma in Africa must be addressed as a matter of urgency in view of the recent statistics from the IOVS survey, and in order to alleviate the plight of the millions of individuals in Africa who unnecessarily lose their eyesight to glaucoma,” added Dr. Coleman. , Lumenis supported a successful mission to treat children with burn injuries.  The mission, led by R. Rox Anderson, MD, Director of the Wellman Center for Photomedicine and Professor of Dermatology at Harvard Medical School, was designed to provide immediate access to treatment for patients in need, but also to help local medical leaders establish a sustainable burn injury care network in Armenia. The Lumenis , the most powerful CO2 laser system for scar evision procedures, with the unique SCAARFX mode, was used in the mission. It has also been used in similar humanitarian initiatives in Russia, China and Vietnam, and is considered the standard of care for treating soldiers injured in battle, for example in the VA hospitals in the USA. In Haiti, Lumenis is supporting the efforts of the St. Luke Foundation for Haiti and Dr. Mitchell Humphreys of the Mayo Clinic Dr. Rox Anderson treats children suffering from burn injuries with Lumenis’ UltraPulse SCAAR FX laser system